Researchers Create Gene Test to Suggest Best Therapy for Colorectal Cancer Patients
By measuring the activity of four genes in cancer cells, scientists at the Albert Einstein College of Medicine accurately predicted whether colorectal tumors are sensitive or resistant to 5-Fluorouracil (5-FU), an important chemotherapy drug.
First Rigorous Test Of Magnetic Stimulation Device Shows Promise For Short-Circuiting Migraines
Migraine sufferers can take treatment into their own hands by zapping the painful headaches with a hand-held magnetic stimulation device, instead of gulping medication, suggests new data presented at the 50th Annual Scientific Meeting of the American Headache Society.
Encouraging Results Seen in Clinical Trial of Novel Skin Cancer Treatment
Researchers Find Clue In Missing Protein Related to Common Form of Inherited Mental Retardation
More News | Calendar of Events | Publications |
Inside Einstein eNewsletter
The Gottesman gift will support several important research projects at the College of Medicine, most of them to be conducted in the new Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion, which officially opens in June 2008.

Dr. Susan Horwitz' Discovery of How Taxol Works Is Focus of Cover Story & Award Nomination
Thirty years ago, Dr. Susan Band Horwitz' pioneering work uncovered the molecular mechanisms of the antitumor agent Taxol.
Hundreds from the Einstein Community Attended Price Center/Block Research Pavilion Dedication
A giant tent was filled to capacity on Thursday afternoon, June 12th, with additional chairs set up to address the overflow of those attending the official dedication ceremony marking the opening of the Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion. On the beautiful, sunny day, nearly 1,000 took part in the festivities, which included tours of the new research facility.